Geneva, Feb. 13 -- International Clinical Trials Registry received information related to the study (ChiCTR2600118434) titled 'Validation Study of a CT-Based Target Prediction Model for Pancreatic Cancer' on Feb. 5.
Study Type: Diagnostic test
Study Design:
Diagnostic test for accuracy
Primary Sponsor: Fudan University Shanghai Cancer Center
Condition:
pancreatic cancer
Intervention:
Gold Standard:Immunofluorescence staining of the target
Recruitment Status: Not Recruiting
Phase: 0
Date of First Enrollment: 2026-02-09
Target Sample Size: Target condition:100;Difficult condition:0
Countries of Recruitment:
China
To know more, visit https://www.chictr.org.cn/showproj.html?proj=303740
Disclaimer: Curated by HT Syndication....